Wealth Managers Boost QQQ Stakes, but Data Lags Market Moves
Markets Daniel Marsh

Wealth Managers Boost QQQ Stakes, but Data Lags Market Moves

Recent SEC filings reveal two wealth managers raised their stakes in the Invesco QQQ ETF in Q3 2025, though subsequent data shows one trimmed its position by year-end. The Nasdaq-100 tracker traded near $593, down 1.1%, as investors weigh growth prospects against macro risks.

QQQ SPY XLK
Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal
Markets Daniel Marsh

Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal

French pharmaceutical firm Servier will acquire Day One Biopharmaceuticals for $2.5 billion, gaining the pediatric glioma treatment Ojemda. The deal offers a 68% premium to Day One's recent closing price.

NVS
Unusual Machines Shares Surge on Preliminary 2025 Revenue Doubling
Earnings James Calloway

Unusual Machines Shares Surge on Preliminary 2025 Revenue Doubling

Unusual Machines shares climbed 7% Monday following preliminary results showing 2025 revenue more than doubled to $11.2 million and cash reserves topped $103 million. The drone components maker also reported a widened quarterly operating loss.

UMAC
W&T Offshore Posts Wider 2025 Loss Amid Revenue Drop, Sees Regulatory Relief
Earnings James Calloway

W&T Offshore Posts Wider 2025 Loss Amid Revenue Drop, Sees Regulatory Relief

W&T Offshore disclosed a deeper net loss for 2025, with revenue declining to $501.5 million. The company highlighted reduced net debt and potential regulatory relief from proposed offshore financial assurance rules.

WTI TALO MUR USO XLE
Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting
Regulation James Calloway

Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting

Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.

RVPH BMY VNDA XLV
uniQure Shares Soar on FDA Leadership Shift Amid Gene Therapy Dispute
Regulation James Calloway

uniQure Shares Soar on FDA Leadership Shift Amid Gene Therapy Dispute

uniQure shares jumped 34% in premarket trading following news that FDA biologics chief Vinay Prasad will depart in April. The move comes amid a regulatory standoff over the company's Huntington's disease gene therapy.

QURE
Oil Surges Past $100, Stocks Tumble on Geopolitical and Economic Fears
Markets Daniel Marsh

Oil Surges Past $100, Stocks Tumble on Geopolitical and Economic Fears

Brent crude oil surged above $100 per barrel for the first time since 2022 as conflict disrupts the Strait of Hormuz. Wall Street futures fell sharply following disappointing U.S. employment figures.

USO SPY ALK UAL FANG XLE
3D Systems Tops Q4 Forecasts, but Bleak Q1 Outlook Raises Doubts
Earnings James Calloway

3D Systems Tops Q4 Forecasts, but Bleak Q1 Outlook Raises Doubts

3D Systems reported Q4 revenue of $106.3M, exceeding its forecast, though full-year sales fell 12%. The company anticipates a revenue decline and continued losses for the current quarter.

DDD
Aureus Greenway to Acquire Powerus in Strategic Drone Shift, Secures $9M Funding
Technology Sarah Chen

Aureus Greenway to Acquire Powerus in Strategic Drone Shift, Secures $9M Funding

Aureus Greenway Holdings has entered into an agreement to purchase autonomous systems manufacturer Powerus via an all-stock transaction, aiming to take the combined entity public on the Nasdaq. The deal includes a $9 million private placement and a $50 million investment commitment from South Korea's KCGI.

AGH
Markets Brace for Inflation Data as Oil Surge Dents Rate Cut Hopes
Markets Daniel Marsh

Markets Brace for Inflation Data as Oil Surge Dents Rate Cut Hopes

U.S. equity futures declined sharply Monday amid surging oil prices and weak jobs data, pushing back expectations for Federal Reserve rate cuts. Investors await critical inflation reports due this week.

HIMS GE USO
TSX Set for Lower Open as Oil Spike Sparks Inflation, Recession Fears
Markets Daniel Marsh

TSX Set for Lower Open as Oil Spike Sparks Inflation, Recession Fears

Canada's main stock index is poised for a lower open Monday, with futures down 0.92%, after a surge in oil prices to multi-year highs intensified inflation and recession concerns, pressuring financial and mining sectors.

XLE XLF GLD SLV USO RY BMO BNS CM TD BNS RY BMO CM TD BNS RY BMO CM TD
Silver Retreats as Dollar Gains, Oil Spike Delay Rate Cut Bets
Commodities Rebecca Torres

Silver Retreats as Dollar Gains, Oil Spike Delay Rate Cut Bets

Spot silver declined 0.3% to $84.07 per ounce, paring deeper losses, as a strong dollar and soaring oil prices above $119 rattled markets and delayed expectations for U.S. rate cuts.

SLV GLD USO XLE